Opzelura Ruxolitinib Cream – For Vitiligo Price In Pakistan – Original Products

Opzelura Ruxolitinib Cream 1.5% is a prescription topical medicine containing ruxolitinib, a Janus kinase (JAK) inhibitor. It is specifically indicated for the topical treatment of nonsegmental vitiligo in adults and pediatric patients 12 years of age and older. By targeting JAK-related signaling involved in the immune response, ruxolitinib can help support repigmentation of affected skin. Opzelura is applied directly to the affected areas and is generally used twice daily according to a healthcare professional’s instructions. Because it is a prescription medicine with important safety warnings, it should be used under appropriate medical supervision.

Original Formula

• Ruxolitinib – 1.5% (15 mg/g)
• Topical cream formulation
• Cetyl alcohol
• Dimethicone
• Glyceryl stearate
• Mineral oil
• Medium-chain triglycerides
• Propylene glycol
• Purified water
• White petrolatum
• Other inactive ingredients as listed in the official formulation

Benefits

• Indicated for nonsegmental vitiligo
• Supports repigmentation of affected skin
• Targets JAK1/JAK2-related signaling
• Convenient topical cream formulation
• Non-steroidal topical treatment
• Suitable for eligible patients 12 years and older under medical supervision

Uses

• Nonsegmental vitiligo
• Repigmentation support
• Topical management of vitiligo-affected skin
• Dermatologist-supervised vitiligo treatment

How to Use

For nonsegmental vitiligo, the current prescribing information recommends applying a thin layer twice daily to affected areas covering up to 10% of body surface area.

Ingredient Highlight

Ruxolitinib 1.5%: The active pharmaceutical ingredient in Opzelura. Ruxolitinib inhibits JAK1 and JAK2 signaling pathways involved in immune and inflammatory processes. Its role in vitiligo treatment is to help address immune signaling associated with melanocyte loss and support repigmentation.